πŸ‡ΊπŸ‡Έ FDA
Patent

US 9255260

Cytotoxic ribonuclease variants

granted A61KA61K38/00A61P

Quick answer

US patent 9255260 (Cytotoxic ribonuclease variants) held by The Regents of the University of California expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K38/00, A61P, A61P35/00